We are encouraged by the weight loss profile of CagriSema demonstrating superiority over both semaglutide and cagrilintide, Martin Holst Lange, Novos executive vice president for development, said in a statement
Graphical Abstract 1 Introduction Vitamin D 3 deficiency constitutes a critical global public health crisis affecting over one billion individuals worldwide, with particularly high prevalence among pregnant women, obese populations, and the elderly ( 3 serves as a pivotal nexus bridging the endocrine and immune systems, with functions extending far beyond its classical role in calcium-phosphorus homeostasis
GLP-1 Receptor Agonists (GLP-1RAs) are a class of pharmacotherapeutic agents that mimic the physiological actions of endogenous GLP-1 [5]
Documentation discipline still matters: source of API, evidence of GMP, vendor qualification, patient consent that explicitly explains the FDA approval status, and a clinical rationale tied to the individual patients condition